2025年5月28日 周三
Home > Archive>Volume 31, Issue 11, 2023 >995-1000
PDF HTML XML Export Cite reminder
Research progress of the effect of intestinal flora on the pathogenesis of atherosclerotic cardiovascular disease
Author:
Affiliation:

1.Xi'an Medical University, Xi'an, Shaanxi 710068, China;2.Department of Cardiology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi 710068, China)

Clc Number:

R5

  • Article
    • | |
  • Metrics
    • |
  • Reference [38]
    • | | | |
  • Comments
    Abstract:

    Artery stenosis due to atherosclerosis is the most common cause of cardiovascular disease. In addition to known risk factors, researchers have found that intestinal flora can influence the pathogenesis of atherosclerosis through its metabolites (short-chain fatty acids, trimethylamine oxide, indoles), the metabolism of bile acids, and the inflammatory response, and the relevant evidence has been supported experimentally. This article presents a systematic review of the relationship between intestinal flora and atherosclerotic cardiovascular disease, the microscopic mechanisms by which intestinal flora affect the pathogenesis of atherosclerotic cardiovascular disease, and recent advances in the treatment of atherosclerotic cardiovascular disease using intestinal flora as a target.

    Reference
    [1] MARZULLO P, DI RENZO L, PUGLIESE G, et al.From obesity through gut microbiota to cardiovascular diseases:a dangerous journey.Int J Obes Suppl, 0,0(1):35-49.
    [2] BAIGENT C, BLACKWELL L, EMBERSON J, et al.Efficacy and safety of more intensive lowering of LDL cholesterol:a Meta-analysis of data from 0,0 participants in 26 randomized trials.Lancet, 0,6(9753):1670-1681.
    [3] WILSON A S, KOLLER K R, RAMABOLI M C, et al.Diet and the human gut microbiome:an international review.Dig Dis Sci, 0,5(3):723-740.
    [4] BARAGETTI A, SEVERGNINI M, OLMASTRONI E, et al.Gut microbiota functional dysbiosis relates to individual diet in subclinical carotid atherosclerosis.Nutrients, 1,3(2):304.
    [5] YU H, LI L, DENG Y, et al.The relationship between the number of stenotic coronary arteries and the gut microbiome in coronary heart disease patients.Front Cell Infect Microbiol, 2,2:903828.
    [6] JIE Z Y, XIA H H, ZHONG S L, et al.The gut microbiome in atherosclerotic cardiovascular disease.Nat Commun, 7,8(1):845.
    [7] MENNI C, LIN C, CECELJA M, et al.Gut microbial diversity is associated with lower arterial stiffness in women.Eur Heart J, 8,9(25):2390-2397.
    [8] 于佳琪, 齐桂红, 郭鹏, 等.肠道菌群对动脉粥样硬化发病的影响及机制.国际药学研究杂志, 9,6(4):256-0,2.YU J Q, QI G H, GUO P, et al.Effect of intestinal flora on the pathogonesis of atherosclerosis and its mechanism.J Int Pharm Res, 9,6(4):256-0,2.
    [9] BRANDSMA E, KLOOSTERHUIS N J, KOSTER M, et al.A proinflammatory gut microbiota increases systemic inflammation and accelerates atherosclerosis.Circ Res, 9,4(1):94-100.
    [10] SU X M, GAO Y H, YANG R C.Gut microbiota-derived tryptophan metabolites maintain gut and systemic homeostasis.Cells, 2,1(15):2296.
    [11] 李森, 贾子衡, 魏雪睿, 等.胆汁酸的代谢稳态调控作用综述.上海交通大学学报(医学版), 0,0(8):1126-1130.LI S, JIA Z H, WEI X R.Role of bile acid on maintaining metabolic homeostasis.J Shanghai Jiaotong Univ MedSci, 0,0(8):1126-1130.
    [12] DEGIROLAMO C, RAINALDI S, BOVENGA F, et al.Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice.Cell Rep, 4,7(1):12-18.
    [13] CHEN X F, CHEN X Q, TANG X Q.Short-chain fatty acid, acylation and cardiovascular diseases.Clin Sci (Lond), 0,4(6):657-676.
    [14] LAZAR V, DITU L M, PIRCALABIORU G G, et al.Gut microbiota, host organism, and diet trialogue in diabetes and obesity.Front Nutr, 9,6:21.
    [15] ZHENG M X, YANG X Y, WU Q Y, et al.Butyrate attenuates hepatic steatosis induced by a high-fat and fiber-deficient diet via the hepatic GPR41/43-CaMKII/HDAC1-CREB pathway.Mol Nutr Food Res, 3,7(1):e2200597.
    [16] CHEN Z L, RADJABZADEH D, CHEN L M, et al.Association of insulin resistance and type 2 diabetes with gut microbial diversity:a microbiome-wide analysis from population studies.JAMA Netw Open, 1,4(7):e2118811.
    [17] JIANG S, SHUI Y, CUI Y, et al.Gut microbiota-dependent trimethylamine N-oxide aggravates angiotensin II-induced hypertension.Redox Biol, 1,6:102115.
    [18] CAO H, ZHU Y, HU G, et al.Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?.Pharmacol Res, 3,7:106586.
    [19] HOSEINI-TAVASSOL Z, HASANI-RANJBAR S.Targeting TMAO and its metabolic pathway for cardiovascular diseases treatment.J Diabetes Metab Disord, 1,0(1):1095-1097.
    [20] GREGORY J C, BUFFA J A, ORG E, et al.Transmission of atherosclerosis susceptibility with gut microbial transplantation.J Biol Chem, 5,0(9):5647-5660.
    [21] CHEN C Y, LEU H B, WANG S C, et al.Inhibition of trimethylamine N-oxide attenuates neointimal formation through reduction of inflammasome and oxidative stress in a mouse model of carotid artery ligation.Antioxid Redox Signal, 3,8(1/3):215-233.
    [22] PENG J, XIAO X, HU M, et al.Interaction between gut microbiome and cardiovascular disease.Life Sci, 8,4:153-157.
    [23] QUERIO G, ANTONIOTTI S, GEDDO F, et al.Modulation of endothelial function by TMAO, a gut microbiota-derived metabolite.Int J Mol Sci, 3,4(6):5806.
    [24] MAKSYMIUK K M, SZUDZIK M, GAWRYS＇-KOPCZYN＇SKA M, et al.Trimethylamine, a gut bacteria metabolite and air pollutant, increases blood pressure and markers of kidney damage including proteinuria and KIM-1 in rats.J Transl Med, 2,0(1):470.
    [25] MELHEM N J, TALEB S.Tryptophan:from diet to cardiovascular diseases.Int J Mol Sci, 1,2(18):9904.
    [26] MICHAEL H, SRIVASTAVA V, DEBLAIS L, et al.The combined escherichia coli nissle 1917 and tryptophan treatment modulates immune and metabolome responses to human rotavirus infection in a human infant fecal microbiota-transplanted malnourished gnotobiotic pig model.mSphere, 2,7(5):e0027022.
    [27] YAN F, FENG Y, CHEN J, et al.Klotho downregulation contributes to myocardial damage of cardiorenal syndrome in sepsis.Mol Med Rep, 0,2(2):1035-1043.
    [28] IACOBINI C, VITALE M, HAXHI J, et al.Mutual regulation between redox and hypoxia-inducible factors in cardiovascular and renal complications of diabetes.Antioxidants (Basel), 2,1(11):2183.
    [29] 杨启娟, 苏晓灵.炎症因子与急性心肌梗死的研究进展.中国动脉硬化杂志, 3,1(7):639-644.YANG Q J, SU X L.Research progress on inflammatory factor and acute myocardial infarction .Chin J Atheroscler, 3,1(7):639-644.
    [30] KIM E S, YOON B H, LEE S M, et al.Fecal microbiota transplantation ameliorates atherosclerosis in mice with C1q/TNF-related protein 9 genetic deficiency.Exp Mol Med, 2,4(2):103-114.
    [31] ZHU W F, GREGORY J C, ORG E, et al.Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk.Cell, 6,5(1):111-124.
    [32] WANG X, YANG J, QIU X, et al.Probiotics, prebiotics, and synbiotics in the treatment of pre-diabetes:a systematic review of randomized controlled trials.Front Public Health, 1,9:645035.
    [33] YOSHIFUJI A, WAKINO S, IRIE J, et al.Oral adsorbent AST-120 ameliorates gut environment and protects against the progression of renal impairment in CKD rats.Clin Exp Nephrol, 8,2(5):1069-1078.
    [34] LIU C, LI Z, SONG Z, et al.Choline and butyrate beneficially modulate the gut microbiome without affecting atherosclerosis in APOE*3-Leiden.CETP mice.Atherosclerosis, 2,2:47-55.
    [35] KUKA J, LIEPINSH E, MAKRECKA-KUKA M, et al.Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.Life Sci, 4,7(2):84-92.
    [36] ZHENG Y, SHI Y, YANG X, et al.Effects of resveratrol on lipid metabolism in liver of red tilapia oreochromis niloticus.Comp Biochem Physiol C Toxicol Pharmacol, 2,1:109408.
    [37] XU M, LV C, WANG H, et al.Peanut skin extract ameliorates high-fat diet-induced atherosclerosis by regulating lipid metabolism, inflammation reaction, and gut microbiota in ApoE－/－ mice.Food Res Int, 2,4:111014.
    [38] QI Y, LIU W, YAN X, et al.Tongxinluo may alleviate inflammation and improve the stability of atherosclerotic plaques by changing the intestinal flora.Front Pharmacol, 2,3:805266.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

ZHAI Jiacheng, WANG Ting, LIU Fuqiang, WANG Junkui. Research progress of the effect of intestinal flora on the pathogenesis of atherosclerotic cardiovascular disease[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2023,31(11):995-1000.

Copy
Share
Article Metrics
  • Abstract:628
  • PDF: 741
  • HTML: 0
  • Cited by: 0
History
  • Received:March 15,2023
  • Revised:May 04,2023
  • Online: December 05,2023
Article QR Code

You are the 49849 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025